奥拉巴里布可以增强BRCA-熟练的乳腺癌细胞对X射线和质子的敏感性
Sohee Park1, Changhoon Choi2, Haeyoung Kim3,4
1Department of Radiation Oncology, Samsung Medical Center, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
Breast cancer research and treatment
|October 30, 2023
概括
奥拉巴里布通过增加DNA损伤和细胞死亡来增强乳腺癌的质子辐射疗法. 这种组合疗法比X射线辐射更有效,特别是与ATR抑制剂结合使用时.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 分子生物学分子生物学
背景情况:
- 乳腺癌 (BC) 治疗通常涉及放射治疗.
- 像Olaparib这样的PARP抑制剂因其辐射敏感化潜力而受到探索.
- 了解质子与X射线辐射的差异效应至关重要.
研究的目的:
- 为了比较Olaparib的放射敏感作用与BRCA-熟练的乳腺癌细胞中的质子和X射线辐射.
- 调查Olaparib对DNA损伤修复和细胞周期进展的影响.
- 评估Olaparib与质子辐射和ATR抑制剂的协同效应.
主要方法:
- 使用了两个具有BRCA能力的BC细胞系 (MDA-MB-231和T47D).
- 评估了细胞增殖 (CCK-8),辐射敏感性 (克隆原检测),细胞周期和细胞亡 (流细胞计).
- 评估了DNA损伤动力学 (γH2AX,彗星测定) 和3D球形状的生长.
主要成果:
- 奥拉巴里布使两种细胞系对质子和X射线辐射敏感,在MDA-MB-231细胞中效果更大.
- 质子辐射显示了比X射线辐射更明显的Olaparib增强.
- 奥拉巴里布增强了辐射诱导的DNA损伤,细胞亡和细胞循环停止;ATR抑制剂进一步提高了质子辐射敏感性.
结论:
- 奥拉巴里布可以提高BRCA富有的乳腺癌细胞的辐射效率.
- 与X射线相比,质子辐射证明了Olaparib与X射线相比具有更高的辐射敏感性.
- 与Olaparib和ATR抑制剂的联合治疗显示出对质子辐射增强的承诺.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Long-patch Base Excision Repair
7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K
Nucleotide Excision Repair
3.5K
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.5K
Mutations
38.0K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
38.0K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K


